Cancer mouse rights sale agreed: US firm is first to exploit controversial invention
Moves to patent the controversial animal as an 'invention' sparked a wave of protest across Europe last year by groups outraged at the prospect that Harvard University, its developers, could make money from the animal's designer cancers.
However, Merck is the first major company to show any interest in exploiting the so- called 'OncoMouse' in the five years since it went on sale in the US. The European Patent Office has yet to decide whether it can be classed as a patentable invention.
The Merck deal is a relief for Du Pont, the chemicals giant behind the OncoMouse, which has invested between pounds 6m and pounds 10m over 10 years in the project. It had hoped this and similar mouse models would open up potentially lucrative drugs markets, and help scientists studying conditions ranging from heart disease to Aids. In practice, it has become an embarrassment.
Public revulsion at the concept of an animal engineered to develop cancer, coupled with unease at attempts to patent the animal, have prompted even senior figures within the industry to brand the mouse a public-relations disaster.
Du Pont claims that the OncoMouse is useful in studies of breast, colon, prostate and lung cancer. Merck has not disclosed how much it paid Du Pont, nor the lines of research that it intends to pursue. Opponents argue that, increasingly, scientists are conducting cancer research using cells cultured in the laboratory, and that to promote animal research is a retrograde step.
The European Patent Office (EPO) is trying to decide whether a patent on the animal - granted to Harvard University in 1988 - should be revoked in Europe as 'contrary to morality'. The patent, the first granted on an animal, was given a provisional go-ahead by the EPO in 1991. This provoked objections on moral, technical and legal grounds.
Inquiries by the Independent have established that the EPO has granted Harvard a third extension - to 15 April - to respond to these objections.
The EPO allowed the controversial mouse patent after deciding its potential benefit to humanity outweighed the suffering the extra genes might cause the engineered mice. But Peter Stevenson, political and legal director of Compassion in World Farming, said: 'Our opposition argued that the benefit to humanity had been given too much weight, and the fact that it has taken so long for anyone to come forward to use the technology indicates its limited use.'
He added: 'This is a test case. If we allow genetic engineering and patenting of animals to go ahead, we are giving our blessing to a whole new episode in humanity's exploitation of animals.'
- 1 BBC told new political editor must be 'impartial' with Nick Robinson reportedly stepping down
- 2 Number of young homeless people in Britain is 'more than three times the official figures'
- 3 Humans of New York image of crying gay teen receives best response yet from Ellen DeGeneres
- 4 The map showing the most dangerous tourist destinations in Europe, according to the Foreign Office
- 5 Swedish minister gives strongest case yet on why EU should stop turning away asylum seekers
BBC told new political editor must be 'impartial' with Nick Robinson reportedly stepping down
Isis propaganda video shows 25 Syrian soldiers executed by teenage militants in Palmyra
Number of young homeless people in Britain is 'more than three times the official figures'
Humans of New York image of crying gay teen receives best response yet from Ellen DeGeneres
The map showing the most dangerous tourist destinations in Europe, according to the Foreign Office
More Britons believe that multiculturalism makes the country worse - not better, says poll
Nathan Collier: Montana man inspired by same-sex marriage ruling requests right to wed two wives
Greece crisis: IMF was pushed around by Angela Merkel and Nicholas Sarkozy – and now it is being humiliated
Forget little green men – aliens will look like humans, says Cambridge University evolution expert
Girl, 7, stares down hate preacher at Ohio festival with pro-LGBT rainbow flag gesture
Osborne to cap family benefits at £23,000 – announced ahead of his post-election Budget
£7 - £10 per hour: Recruitment Genius: This care provider is looking for Home ...
£30000 - £35000 per annum: Recruitment Genius: One of the UK's leading web des...
£27000 - £35000 per annum: Recruitment Genius: A growing, successful, friendly...
£16000 - £25000 per annum: Recruitment Genius: This family owned, independent ...